Dr. Hamid Ghandehari and research team receive subcontract funding for NIH R01 grant
Congratulations to Dr. Hamid Ghandehari for receiving funding for an NIH R01 grant “The Function of MS4A3 in Normal and Malignant Hematopoiesis”! This grant focuses on the study of harnessing membrane-spanning four A (MS4A3) for therapy of chronic myeloid leukemia (CML). The Principal Investigator is Dr. Michael Deininger, Versiti Blood Research Institute.
